SEC Form 4 · accession 0001179110-16-026669
MEDICINES CO /DE · MDCO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Hiroaki Shigeta
Director
Period of report
Jun 13, 2016
Accepted (ET)
Jun 20, 2016 · 6:04 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001113481
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 13, 2016 | M | 20,000 | $26.20 | A | 47,396 | D | |
| Common StockF1 | Jun 13, 2016 | S | 20,000 | $36.76 | D | 27,396 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right-to-buy)F3,F2 | $26.20 | Jun 13, 2016 | M | 20,000 | D | — | Apr 9, 2017 | Common Stock | 20,000 | 0 | D |
Explanation of responses
- F1Sales were effected pursuant to a Rule 10b5-1 program adopted by the reporting person.
- F2This option was vested in thirty-six equal installments beginning on May 9, 2007.
- F3Not applicable.